Scott Bruder, MD, PhD

Bruder Consulting & Venture Group, LLC, New York, NY

Scott P. Bruder, MD, PhD, is the Founder and CEO of the Bruder Consulting & Venture Group, providing product development, regulatory, compliance and commercialization support for companies and HCPs engaged in tissue repair and regeneration.  He is the former Chief Medical and Scientific Officer of Stryker Corporation, and a Member of FDA’s Advisory Panel on Cell, Tissue and Gene Therapy. Over the last 25 years he has launched many orthobiologic products while at Osiris, Anika, DePuy, BD, Stryker plus his current client base, published over 125 papers, abstracts and chapters, and received numerous awards from the AAOS, ORS, ABJS and AIMBE. His landmark patents on the use of MSCs for treating orthopaedic conditions shifted the entire field from autologous to allogeneic cell therapy in a variety of companies around the world. Dr. Bruder maintains his academic ties as an Adjunct Professor of Orthopaedic Surgery and Biomedical Engineering at Case Western Reserve University, where he trained and has actively collaborated with Prof. Arnold Caplan since 1985.